SMT-C2100

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSMT-C2100
Drug Alias NameSMT-C2100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSummit Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSummit Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A